Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities
Authors
Keywords
-
Journal
Future Medicinal Chemistry
Volume 5, Issue 7, Pages 809-829
Publisher
Future Science, LTD
Online
2013-05-08
DOI
10.4155/fmc.13.32
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting the intrinsic inflammatory pathway: honokiol exerts proapoptotic effects through STAT3 inhibition in transformed Barrett's cells
- (2012) Chunhua Yu et al. AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY
- Design and synthesis of 4-O-methylhonokiol analogs as inhibitors of cyclooxygenase-2 (COX-2) and PGF1 production
- (2012) Bit Lee et al. BIOORGANIC & MEDICINAL CHEMISTRY
- In vitro growth inhibition of human cancer cells by novel honokiol analogs
- (2012) Jyh Ming Lin et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Honokiol: A Novel Natural Agent for Cancer Prevention and Therapy
- (2012) S. Arora et al. CURRENT MOLECULAR MEDICINE
- The natural products magnolol and honokiol are positive allosteric modulators of both synaptic and extra-synaptic GABAA receptors
- (2012) Mikhail Alexeev et al. NEUROPHARMACOLOGY
- Calpain/SHP-1 Interaction by Honokiol Dampening Peritoneal Dissemination of Gastric Cancer in nu/nu Mice
- (2012) Shing Hwa Liu et al. PLoS One
- Synthesis and neurite growth evaluation of new analogues of honokiol, a neolignan with potent neurotrophic activity
- (2011) Vemula Praveen Kumar et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- An expedient synthesis of honokiol and its analogues as potential neuropreventive agents
- (2011) Subhankar Tripathi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Mechanisms of Osteoclastogenesis Inhibition by a Novel Class of Biphenyl-Type Cannabinoid CB2 Receptor Inverse Agonists
- (2011) Wolfgang Schuehly et al. CHEMISTRY & BIOLOGY
- Apoptosis induced by Magnolia Grandiflora extract in chlorambucil-resistant B-chronic lymphocytic leukemia cells
- (2011) GustavoHoracio Marin et al. Journal of Cancer Research and Therapeutics
- Honokiol inhibits signal transducer and activator of transcription-3 signaling, proliferation, and survival of hepatocellular carcinoma cells via the protein tyrosine phosphatase SHP-1
- (2011) Peramaiyan Rajendran et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Modulation of GABAA-Receptors by Honokiol and Derivatives: Subtype Selectivity and Structure–Activity Relationship
- (2011) Barbara Taferner et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structural Modification of Honokiol, a Biphenyl Occurring in Magnolia officinalis: the Evaluation of Honokiol Analogues as Inhibitors of Angiogenesis and for Their Cytotoxicity and Structure–Activity Relationship
- (2011) Liang Ma et al. JOURNAL OF MEDICINAL CHEMISTRY
- Honokiol produces anti-neoplastic effects on melanoma cells in vitro
- (2011) Patrick W. Mannal et al. JOURNAL OF SURGICAL ONCOLOGY
- Honokiol Arrests Cell Cycle, Induces Apoptosis, and Potentiates the Cytotoxic Effect of Gemcitabine in Human Pancreatic Cancer Cells
- (2011) Sumit Arora et al. PLoS One
- Honokiol Crosses BBB and BCSFB, and Inhibits Brain Tumor Growth in Rat 9L Intracerebral Gliosarcoma Model and Human U251 Xenograft Glioma Model
- (2011) Xianhuo Wang et al. PLoS One
- Honokiol: a promising small molecular weight natural agent for the growth inhibition of oral squamous cell carcinoma cells
- (2011) Xi‐rui Chen et al. International Journal of Oral Science
- Synthesis and microbiological evaluation of honokiol derivatives as new antimicrobial agents
- (2010) Young-Soo Kim et al. ARCHIVES OF PHARMACAL RESEARCH
- Honokiol inhibits gastric tumourigenesis by activation of 15-lipoxygenase-1 and consequent inhibition of peroxisome proliferator-activated receptor-γ and COX-2-dependent signals
- (2010) Shing Hwa Liu et al. BRITISH JOURNAL OF PHARMACOLOGY
- Honokiol Inhibits Epidermal Growth Factor Receptor Signaling and Enhances the Antitumor Effects of Epidermal Growth Factor Receptor Inhibitors
- (2010) R. J. Leeman-Neill et al. CLINICAL CANCER RESEARCH
- Discovery of novel anticancer therapeutics targeting the PI3K/Akt/mTOR pathway
- (2010) Sauveur-Michel Maira et al. Future Medicinal Chemistry
- Distinct Photoacidity of Honokiol from Magnolol
- (2010) Hongmei Li et al. JOURNAL OF FLUORESCENCE
- Involvement of p38 mitogen-activated protein kinase pathway in honokiol-induced apoptosis in a human hepatoma cell line (hepG2)
- (2010) Junfang Deng et al. LIVER INTERNATIONAL
- Signal Transducer and Activator of Transcription-3, Inflammation, and Cancer
- (2009) Bharat B. Aggarwal et al. Annals of the New York Academy of Sciences
- Honokiol, a Multifunctional Antiangiogenic and Antitumor Agent
- (2009) Levi E. Fried et al. ANTIOXIDANTS & REDOX SIGNALING
- Design and synthesis of ten biphenyl-neolignan derivatives and their in vitro inhibitory potency against cyclooxygenase-1/2 activity and 5-lipoxygenase-mediated LTB4-formation
- (2009) Wolfgang Schühly et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Semi-synthesis and anti-proliferative activity evaluation of novel analogues of Honokiol
- (2009) Youfu Luo et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Down-regulation of c-Src/EGFR-mediated signaling activation is involved in the honokiol-induced cell cycle arrest and apoptosis in MDA-MB-231 human breast cancer cells
- (2009) Eun-Jung Park et al. CANCER LETTERS
- Honokiol induces cell apoptosis in human chondrosarcoma cells through mitochondrial dysfunction and endoplasmic reticulum stress
- (2009) Ying-Ju Chen et al. CANCER LETTERS
- Liposomal honokiol, a potent anti-angiogenesis agent, in combination with radiotherapy produces a synergistic antitumor efficacy without increasing toxicity
- (2009) Jia Hu et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Honokiol-mediated Inhibition of PI3K/mTOR Pathway
- (2009) Courtney Crane et al. JOURNAL OF IMMUNOTHERAPY
- Gender differences in expression of the human caspase-12 long variant determines susceptibility to Listeria monocytogenes infection
- (2009) G. Yeretssian et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Improved therapeutic effectiveness by combining liposomal honokiol with cisplatin in lung cancer model
- (2008) Qi-qi Jiang et al. BMC CANCER
- Honokiol, a Constituent of Oriental Medicinal Herb Magnolia officinalis, Inhibits Growth of PC-3 Xenografts In vivo in Association with Apoptosis Induction
- (2008) E.-R. Hahm et al. CLINICAL CANCER RESEARCH
- Honokiol Suppresses Survival Signals Mediated by Ras-Dependent Phospholipase D Activity in Human Cancer Cells
- (2008) A. Garcia et al. CLINICAL CANCER RESEARCH
- Honokiol, a natural therapeutic candidate, induces apoptosis and inhibits angiogenesis of ovarian tumor cells
- (2008) Zhengyu Li et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer
- (2008) Hong Luo et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The natural product honokiol preferentially inhibits cellular FLICE-inhibitory protein and augments death receptor-induced apoptosis
- (2008) S. M. Raja et al. MOLECULAR CANCER THERAPEUTICS
- Synergistic antitumor effects of liposomal honokiol combined with adriamycin in breast cancer models
- (2008) Wenli Hou et al. PHYTOTHERAPY RESEARCH
- Enhancement of therapeutic effectiveness by combining liposomal honokiol with cisplatin in ovarian carcinoma
- (2007) Y. LIU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started